Go Pro

Cooper Companies (COO) Competitors

Cooper Companies logo
$74.37 +0.14 (+0.18%)
As of 02:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.

COO vs. ALC, WST, ALGN, MMSI, and ICUI

Should you buy Cooper Companies stock or one of its competitors? MarketBeat compares Cooper Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cooper Companies include Alcon (ALC), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), and ICU Medical (ICUI).

How does Cooper Companies compare to Alcon?

Alcon (NYSE:ALC) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Alcon7.70% 7.11% 4.98%
Cooper Companies 5.57%10.88%7.27%

53.9% of Alcon shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alcon has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcon$10.40B3.37$980M$1.6642.65
Cooper Companies$4.09B3.54$374.90M$1.1863.02

Alcon presently has a consensus price target of $84.76, indicating a potential upside of 19.72%. Cooper Companies has a consensus price target of $81.36, indicating a potential upside of 9.40%. Given Alcon's stronger consensus rating and higher possible upside, analysts plainly believe Alcon is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35

In the previous week, Cooper Companies had 17 more articles in the media than Alcon. MarketBeat recorded 17 mentions for Cooper Companies and 0 mentions for Alcon. Cooper Companies' average media sentiment score of 0.91 beat Alcon's score of 0.50 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Overall Sentiment
Alcon Positive
Cooper Companies Positive

Summary

Alcon beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

West Pharmaceutical Services presently has a consensus target price of $368.08, indicating a potential upside of 5.97%. Cooper Companies has a consensus target price of $81.36, indicating a potential upside of 9.40%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
3.00
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35

In the previous week, Cooper Companies had 6 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 17 mentions for Cooper Companies and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.63 beat Cooper Companies' score of 0.91 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
10 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Cooper Companies
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.98% 20.11% 14.83%
Cooper Companies 5.57%10.88%7.27%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B7.95$493.70M$7.8144.47
Cooper Companies$4.09B3.54$374.90M$1.1863.02

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

West Pharmaceutical Services has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Cooper Companies (NASDAQ:COO) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

Align Technology has lower revenue, but higher earnings than Cooper Companies. Align Technology is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.54$374.90M$1.1863.02
Align Technology$4.03B3.07$410.35M$5.7530.06

Cooper Companies currently has a consensus target price of $81.36, indicating a potential upside of 9.40%. Align Technology has a consensus target price of $206.36, indicating a potential upside of 19.40%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Align Technology had 13 more articles in the media than Cooper Companies. MarketBeat recorded 30 mentions for Align Technology and 17 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.91 beat Align Technology's score of 0.87 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
15 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology has a net margin of 9.99% compared to Cooper Companies' net margin of 5.57%. Align Technology's return on equity of 15.86% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Align Technology 9.99%15.86%10.32%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Align Technology beats Cooper Companies on 11 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Merit Medical Systems?

Cooper Companies (NASDAQ:COO) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

Cooper Companies has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.54$374.90M$1.1863.02
Merit Medical Systems$1.52B3.36$128.49M$2.4235.26

In the previous week, Merit Medical Systems had 16 more articles in the media than Cooper Companies. MarketBeat recorded 33 mentions for Merit Medical Systems and 17 mentions for Cooper Companies. Merit Medical Systems' average media sentiment score of 1.14 beat Cooper Companies' score of 0.91 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
15 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to Cooper Companies' net margin of 5.57%. Merit Medical Systems' return on equity of 13.75% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Merit Medical Systems 9.22%13.75%8.10%

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cooper Companies currently has a consensus target price of $81.36, indicating a potential upside of 9.40%. Merit Medical Systems has a consensus target price of $100.30, indicating a potential upside of 17.54%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

Summary

Merit Medical Systems beats Cooper Companies on 10 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Cooper Companies had 4 more articles in the media than ICU Medical. MarketBeat recorded 17 mentions for Cooper Companies and 13 mentions for ICU Medical. Cooper Companies' average media sentiment score of 0.91 beat ICU Medical's score of 0.73 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
9 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 2.15%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical2.15% 7.50% 3.91%
Cooper Companies 5.57%10.88%7.27%

ICU Medical currently has a consensus target price of $172.00, suggesting a potential upside of 0.39%. Cooper Companies has a consensus target price of $81.36, suggesting a potential upside of 9.40%. Given Cooper Companies' higher probable upside, analysts clearly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.16B1.99$730K$1.8592.61
Cooper Companies$4.09B3.54$374.90M$1.1863.02

ICU Medical has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Cooper Companies beats ICU Medical on 11 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$14.50B$5.70B$6.80B$13.01B
Dividend YieldN/A1.78%2.60%10.03%
P/E Ratio63.0223.54279.9825.51
Price / Sales3.5459.23649.35116.02
Price / Cash11.9432.5328.6434.82
Price / Book1.796.5011.156.35
Net Income$374.90M$151.72M$3.48B$347.60M
7 Day Performance3.20%6.11%2.51%3.14%
1 Month Performance0.22%0.89%-2.78%-2.08%
1 Year Performance4.08%9.82%64.32%21.27%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
2.9394 of 5 stars
$74.37
+0.2%
$81.36
+9.4%
+4.7%$14.50B$4.09B63.0215,000
ALC
Alcon
3.7183 of 5 stars
$68.83
-1.1%
$84.76
+23.1%
-20.1%$34.14B$10.40B41.5925,942
WST
West Pharmaceutical Services
4.0019 of 5 stars
$336.63
-0.9%
$364.42
+8.3%
+45.4%$23.68B$3.33B43.0810,800
ALGN
Align Technology
3.6791 of 5 stars
$168.50
-2.8%
$206.36
+22.5%
+26.6%$12.09B$4.14B29.3520,290
MMSI
Merit Medical Systems
4.1096 of 5 stars
$84.42
+1.3%
$92.78
+9.9%
+0.9%$5.06B$1.52B36.767,500

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners